摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Pyrimidine, 2-chloro-4,5-bis(4-methylphenyl)-6-(methylthio)- | 651316-37-9

中文名称
——
中文别名
——
英文名称
Pyrimidine, 2-chloro-4,5-bis(4-methylphenyl)-6-(methylthio)-
英文别名
2-chloro-4,5-bis(4-methylphenyl)-6-methylsulfanylpyrimidine
Pyrimidine, 2-chloro-4,5-bis(4-methylphenyl)-6-(methylthio)-化学式
CAS
651316-37-9
化学式
C19H17ClN2S
mdl
——
分子量
340.9
InChiKey
AFGMYBISLNOICY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6
  • 重原子数:
    23
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.16
  • 拓扑面积:
    51.1
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • [EN] NOVEL BIO-ACTIVE MOLECULES<br/>[FR] NOUVELLES MOLECULES BIOACTIVES
    申请人:ORCHID CHEMICALS & PHARM LTD
    公开号:WO2004009560A1
    公开(公告)日:2004-01-29
    The present invention relates to novel derivatives of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel pyrimidine derivatives of the general formula (I).
    本发明涉及一般式(I)的新颖衍生物,它们的衍生物,类似物,互变异构体,立体异构体,多晶形态,水合物,溶剂合物,其药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明更具体提供了一般式(I)的新颖嘧啶衍生物。
  • Novel bio-active molecules
    申请人:Agarwal Kumar Shiv
    公开号:US20050107413A1
    公开(公告)日:2005-05-19
    The present invention relates to novel derivatives of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel pyrimidine derivatives of the general formula (I).
    本发明涉及一般式(I)的新衍生物,其衍生物,类似物,互变异构体,立体异构体,多晶形,水合物,溶剂化物,其药学上可接受的盐和包含它们的药学上可接受的组合物。本发明更具体地提供了一般式(I)的新嘧啶衍生物。
  • NOVEL BIO-ACTIVE MOLECULES
    申请人:Orchid Research Laboratories Limited
    公开号:EP1542978B1
    公开(公告)日:2011-04-13
  • US7317014B2
    申请人:——
    公开号:US7317014B2
    公开(公告)日:2008-01-08
查看更多